Publications by authors named "Fernando Pastor"

Claim this Profile
D
Demonstration of SLU7 as a new cancer target.
Carla Rojo, Aaron Otero, Maria Elizalde, Maria Azkona, Roberto Barbero, Fernando Pastor

Biomed Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-based therapies in liver metabolic diseases.
Antonio Fontanellas, Pedro Berraondo, Francesco Urigo, Daniel Jericó, Paolo G V Martini, Fernando Pastor

Gut· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer.
Borja Ruiz-Fernández de Córdoba, Karmele Valencia, Connor Welch, Haritz Moreno, Susana Martínez-Canarias, Fernando Pastor

Signal Transduct Target Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lockpicking FGFR1 with aptamer-based technology.
Francesca Nonatelli, Fernando Pastor, Fernando Calvo

Mol Ther Nucleic Acids· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models.
Iker Ausejo-Mauleon, Naiara Martinez-Velez, Andrea Lacalle, Daniel de la Nava, Javier Cebollero, Fernando Pastor

JCI Insight· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer.
Ashwathi Puravankara Menon, Helena Villanueva, Daniel Meraviglia-Crivelli, Hisse M van Santen, Joschka Hellmeier, Fernando Pastor

Mol Ther Nucleic Acids· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals.
Eric Rovira, Beatriz Moreno, Nerea Razquin, Lorea Blázquez, Ruben Hernández-Alcoceba, Fernando Pastor

ACS Nano· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.
Iker Ausejo-Mauleon, Sara Labiano, Daniel de la Nava, Virginia Laspidea, Marta Zalacain, Fernando Pastor

Cancer Cell· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating T Cell Responses by Targeting CD3.
Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, Francesca Nonatelli, Helena Villanueva, Fernando Pastor

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma.
Ane Amundarain, Fernando Pastor, Felipe Prósper, Xabier Agirre

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction.
Daniel Meraviglia-Crivelli, Helena Villanueva, Angelina Zheleva, María Villalba-Esparza, Beatriz Moreno, Fernando Pastor

Mol Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression.
Daniel Meraviglia-Crivelli, Helena Villanueva, Ashwathi Puravankara Menon, Angelina Zheleva, Beatriz Moreno, Fernando Pastor

Mol Ther Nucleic Acids· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System.
Daniel Meraviglia-Crivelli, Angelina Zheleva, Martin Barainka, Beatriz Moreno, Helena Villanueva, Fernando Pastor

Biomedicines· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U1A is a positive regulator of the expression of heterologous and cellular genes involved in cell proliferation and migration.
Eric Rovira, Beatriz Moreno, Nerea Razquin, Roland Hjerpe, Monika Gonzalez-Lopez, Fernando Pastor

Mol Ther Nucleic Acids· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
Erkuden Casales, Eva Martisova, Helena Villanueva, Ascensión López Díaz de Cerio, Susana Inoges, Fernando Pastor

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotide-Based Therapies for Renal Diseases.
Fernando Cartón-García, Cassondra Jeanette Saande, Daniel Meraviglia-Crivelli, Rafael Aldabe, Fernando Pastor

Biomedicines· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
Mayte Sola, Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, Mario Martínez Soldevilla, Fernando Pastor

Mol Ther Nucleic Acids· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity.
Mario Martínez Soldevilla, Helena Villanueva, Daniel Meraviglia-Crivelli, Ashwathi Puravankara Menon, Marta Ruiz, Fernando Pastor

Mol Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An RNA toolbox for cancer immunotherapy.
Fernando Pastor, Pedro Berraondo, Iñaki Etxeberria, Josh Frederick, Ugur Sahin

Nat Rev Drug Discov· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer-iRNAs as Therapeutics for Cancer Treatment.
Mario M Soldevilla, Daniel Meraviglia-Crivelli de Caso, Ashwathi P Menon, Fernando Pastor

Pharmaceuticals (Basel)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.
Guillermo Aldave, Marisol Gonzalez-Huarriz, Angel Rubio, Juan Pablo Romero, Datta Ravi, Fernando Pastor

Neuro Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors.
Mario M Soldevilla, Helena Villanueva, Naiara Martinez-Velez, Daniel Meraviglia-Crivelli, Marta M Alonso, Fernando Pastor

Oncoimmunology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoy-Based, Targeted Inhibition of STAT3: A New Step forward for B Cell Lymphoma Immunotherapy.
Mario M Soldevilla, Fernando Pastor

Mol Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA).
Mario Martínez Soldevilla, Sandra Hervas, Helena Villanueva, Teresa Lozano, Obdulia Rabal, Fernando Pastor

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.
Susana Inogés, Sonia Tejada, Ascensión López-Díaz de Cerio, Jaime Gállego Pérez-Larraya, Jaime Espinós, Fernando Pastor

J Transl Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis